Proxy Voting Records Glossary

Fidelity Advisor Biotechnology Fund For the 12 month period: Jul 1, 2007 and Jun 30, 2008 ARRAY BIOPHARMA INC. Meeting Type: Annual Ticker: ARRY Security ID: 04269X105 Meeting Date: Nov 1, 2007 Proposed by: Management Back to Meetings # Proposal Management Recommendation Vote 1.1 ELECT DAVID L. SNITMAN, PH.D. AS A DIRECTOR For For 1.2 ELECT GIL J. VAN LUNSEN AS A DIRECTOR For For 1.3 ELECT J.L. ZABRISKIE, PH.D. AS A DIRECTOR For For 2 APPROVAL OF AN AMENDMENT TO THE ARRAY BIOPHARMA INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 60,000,000 TO 120,000,000. For For 3 RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING JUNE 30, 2008. For For     Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. © Copyright 1998-2009 FMR LLC. All rights reserved. Terms of Use  Privacy  Security  Site Map